Dr. Smith is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
1665 Aurora Ct
Aurora, CO 80045Phone+1 720-848-0300Fax+1 720-848-0360
Education & Training
- Memorial Sloan Kettering Cancer CenterFellowship, Hematology and Medical Oncology, 1991 - 1992
- University of Texas Southwestern Medical CenterResidency, Internal Medicine, 1984 - 1985
- University of Texas Southwestern Medical SchoolClass of 1984
- Rice UniversityB.A., Biology, 1975 - 1979
Certifications & Licensure
- CO State Medical License 2012 - 2025
- PA State Medical License 2010 - 2012
- FL State Medical License 2002 - 2004
- NC State Medical License 1993 - 2003
- TX State Medical License 1985 - 1987
- American Board of Internal Medicine Internal Medicine
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2013
- Best Doctors Denver Business Journal, 2013
- Best Doctors in Pittsburgh Pittsburgh Magazine, 2012
- Join now to see all
Publications & Presentations
PubMed
- 1 citationsTargeting Acute Myeloid Leukemia Stem Cells through Perturbation of Mitochondrial Calcium.Anagha Inguva Sheth, Mark J Althoff, Hunter Tolison, Krysta Engel, Maria L Amaya
Cancer Discovery. 2024-10-04 - Outcomes of Haplo-Cord Versus Dual Cord Transplants: A Single-Center Retrospective Analysis.Andrew Kent, Kellen B Gil, Michael K Jones, Brooke Linden, Enkhee Purev
Transplantation and Cellular Therapy. 2024-08-17 - 2 citationsLysosomal acid lipase A modulates leukemia stem cell response to venetoclax/tyrosine kinase inhibitor combination therapy in blast phase chronic myeloid leukemia.Mohd Minhajuddin, Amanda Winters, Haobin Ye, Shanshan Pei, Brett Stevens
Haematologica. 2024-06-27
Journal Articles
- Venetoclax with Azacitidine Disrupts Energy Metabolism and Targets Leukemia Stem Cells in Patients with Acute Myeloid LeukemiaDaniel A Pollyea, Jonathan A Gutman, Enkhtsetseg Purev, Clayton Smith, Nature
- ALDHs in hematopoietic stem cells and leukemagenesisSmith C, Gasparetto M, Jordan CT, Pollyea DA, Humphries KH, Vasiliou V, NYAS, 1/1/2014
- Fludarabine and cytarabine in patients with relapsed actute myeloid leukemiaMcLaughlin B, Im A, Raptis A, Hou JZ, Redner R, Duggal S, Lin Y, Smith C, Boyiadzis M, Int J Hematol, 1/1/2012
- Join now to see all
Books/Book Chapters
Abstracts/Posters
- Broad Efficacy of the Translation Inhibitor Omacetaxine in Relapsed/Refractory Multiple Myeloma SamplesClayton Smith, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
- A Phase 2 Study of Glasdegib for the Treatment of Acute Myeloid Leukemia and Myelodysplastic Syndrome Patients with High Risk of Post-Allogeneic Stem Cell Transplantat...Clayton Smith, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
- Outcomes Following Allogeneic Stem Cell Transplantation for AML in First Completion Remission Are Comparable between MRD Negative Patients and MRD Positive Patients Re...Clayton Smith, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
Lectures
- Targeted therapies for hematologic malignanciesUniversity of Colorado - 1/1/2016
- Waldenstrom's macroglobulinemiaUniversity of Colorado, 2012, 2013, 2014, 2015, 2016 - 1/1/2016
- AmyloidosisUniversity of Colorado, 2012, 2013, 2014, 2015, 2016 - 1/1/2016
- Join now to see all
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: